Literature DB >> 15262616

Randomized controlled versus naturalistic studies: a new research agenda.

Falk Leichsenring1.   

Abstract

The present article addresses the question of what kind of evidence is required to demonstrate that a method of psychotherapy works. Referring to recent conceptualizations of the logical structure of scientific theories, that is, the structuralistic view of theories, the author shows that randomized controlled studies (RCTs) and naturalistic studies (effectiveness studies) refer to different domains of intended applications (laboratory vs. field). This view has several important implications: (1) RCTs and naturalistic studies do not differ concerning their internal and external validity; (2) naturalistic studies do not necessarily provide lower-level evidence than RCTs; (3) evidence from RCTs cannot be transferred to psychotherapeutic practice in the field; (4) naturalistic studies are required to demonstrate that a form of therapy works in the field; (5) The proposed catalogues for levels of evidence focus on RCTs; thus, they cannot be applied to the question if a therapy works in the field; (6) It is necessary to define separate criteria for levels of evidence of naturalistic studies; and (7) a new research agenda for naturalistic studies can be derived, which is analogous to that of efficacy studies. In this article, a proposal is made to define levels of evidence of naturalistic studies. A gold standard for naturalistic studies is proposed.

Mesh:

Year:  2004        PMID: 15262616     DOI: 10.1521/bumc.68.2.137.35952

Source DB:  PubMed          Journal:  Bull Menninger Clin        ISSN: 0025-9284


  21 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 2.  The effectiveness of cognitive behavioral therapy for personality disorders.

Authors:  Alexis K Matusiewicz; Christopher J Hopwood; Annie N Banducci; C W Lejuez
Journal:  Psychiatr Clin North Am       Date:  2010-09

3.  Naturalistic study on the effectiveness of psycho-oncological interventions in cancer patients and their partners.

Authors:  J Barth; S Delfino; A Künzler
Journal:  Support Care Cancer       Date:  2013-01-10       Impact factor: 3.603

4.  [Indication of psychoanalytic treatment for personality disorders].

Authors:  Hemma Rössler-Schülein; Henriette Löffler-Stastka; Christine Diercks; Elisabeth Skale
Journal:  Wien Med Wochenschr       Date:  2007

5.  Evidentiary Pluralism as a Strategy for Research and Evidence-Based Practice in Rehabilitation Psychology.

Authors:  Jalie A Tucker; Geoffrey M Reed
Journal:  Rehabil Psychol       Date:  2008-08

6.  Improving Quality of Life for Patients with Major Depressive Disorder by Increasing Hope and Positive Expectations with Future Directed Therapy (FDT).

Authors:  Jennice S Vilhauer; Julissa Cortes; Nazanin Moali; Sally Chung; James Mirocha; Waguih William Ishak
Journal:  Innov Clin Neurosci       Date:  2013-03

7.  Narrating uncertainties about treatment of mental health conditions.

Authors:  Frances L Rapport; Gabi S Jerzembek; Marcus A Doel; Aled Jones; Matteo Cella; Keith R Lloyd
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-24       Impact factor: 4.328

8.  Early diagnosis of autism and impact on prognosis: a narrative review.

Authors:  Elisabeth Fernell; Mats Anders Eriksson; Christopher Gillberg
Journal:  Clin Epidemiol       Date:  2013-02-21       Impact factor: 4.790

9.  Lessons Learned during a Naturalistic Study of Online Treatment for Pediatric Rehabilitation.

Authors:  Naomi Gefen; Shoshana Steinhart; Maurit Beeri; Patrice L Weiss
Journal:  Int J Environ Res Public Health       Date:  2021-06-21       Impact factor: 3.390

10.  Short and long-term effectiveness of couple counselling: a study protocol.

Authors:  Margot J Schofield; Nicholas Mumford; Dubravko Jurkovic; Ivancica Jurkovic; Andrew Bickerdike
Journal:  BMC Public Health       Date:  2012-09-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.